1、The Pulse 2024Global R&D insights in pharmaceuticals Thought leadershipppdMethodology 4 Executive summary 9Detailed findings:Industry trends and challenges 16Detailed findings:Hot topics 27Detailed findings:Outsourcing 32Appendix 37Contents2The Pulse 2024 Thermo Fisher Scientific Inc.All rights rese

2、rved.All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified.About The PulseThe future for drug developers is defined by how effectively they adopt innovative strategies and new technologies,while navigating industry challenges and complexities.Tha

3、ts why the PPD clinical research business of Thermo Fisher Scientific surveyed 150 leaders at biotech and pharmaceutical organizations around the globe to assess trends in drug discovery and development.Respondents shared the therapeutic areas in their pipelines,barriers to bringing drugs to market,

4、innovations that are driving transformation,and attitudes toward key topics such as outsourcing,patient recruitment,diversity,decentralized trials,and more.In our third annual report,youll go beyond the data to learn what these insights mean for drug developers across the globe,and how you can prepa

5、re to successfully navigate the evolving drug development landscape.Discover what industry leaders are facing today,and how their outlook on pharmaceutical research and development is pushing the industry forward.3The Pulse 2024 Thermo Fisher Scientific Inc.All rights reserved.All trademarks are the

6、 property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified.Methodology4The Pulse 2024 Thermo Fisher Scientific Inc.All rights reserved.All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified.Methodology Participants were